Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience

Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience

Background & Aims: Hepatocellular Carcinoma (HCC) is the sixth most common malignancy and the third most common cause of cancer mortality worldwide. We aimed to assess the effect of novel treatment options on the survival of HCC patients.

Bibliographic Details
Main Authors: Moore, Assaf, Cohen-Naftaly, Michal, Benjaminov, Ofer, Braun, Marius, Issachar, Assaf, Mor, Eitan, Tovar, Anna, Sarfaty, Michal, Gordon, Noa, Stemmer, Salomon M.
Format: Online
Language:English
Published: Ivyspring International Publisher 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910579/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910579/

Similar Items